Page last updated: 2024-10-22

antipyrine and Cognitive Decline

antipyrine has been researched along with Cognitive Decline in 2 studies

Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, P1
Cao, J1
Liu, N1
Ma, L1
Zhou, X1
Zhang, H1
Wang, Y1
Reeta, KH1
Singh, D1
Gupta, YK1

Other Studies

2 other studies available for antipyrine and Cognitive Decline

ArticleYear
Protective Effects of Edaravone in Adult Rats with Surgery and Lipopolysaccharide Administration-Induced Cognitive Function Impairment.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: Animals; Antipyrine; Brain; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Edaravone; Fre

2016
Edaravone attenuates intracerebroventricular streptozotocin-induced cognitive impairment in rats.
    The European journal of neuroscience, 2017, Volume: 45, Issue:7

    Topics: Animals; Antipyrine; Cerebral Cortex; Cholinesterases; Cognitive Dysfunction; Cytokines; Edaravone;

2017